Brian Datnow

1.4k total citations
16 papers, 444 citations indexed

About

Brian Datnow is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Brian Datnow has authored 16 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Brian Datnow's work include Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Brian Datnow is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Brian Datnow collaborates with scholars based in United States, India and Japan. Brian Datnow's co-authors include Catherine Denicourt, Cheryl Saenz, Steven F. Dowdy, Sarah G Boles, Lyudmila Bazhenova, Nicholas J. G. Webster, Scott M. Lippman, Maria Schwaederlé, Barbara A. Parker and Paul T. Fanta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Brian Datnow

16 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Datnow United States	8	254	173	168	116	57	16	444
Ann Boguniewicz United States	10	219 0.9×	131 0.8×	207 1.2×	100 0.9×	99 1.7×	18	429
Hoiseon Jeong South Korea	11	295 1.2×	192 1.1×	153 0.9×	90 0.8×	98 1.7×	24	552
Jamie L. DellaGatta United States	6	299 1.2×	273 1.6×	119 0.7×	67 0.6×	41 0.7×	8	658
Marco Petronio France	4	407 1.6×	166 1.0×	313 1.9×	113 1.0×	37 0.6×	5	567
Ralf Kemmerling Austria	14	174 0.7×	244 1.4×	155 0.9×	109 0.9×	55 1.0×	29	518
Marissa S. Mattar United States	12	313 1.2×	290 1.7×	175 1.0×	230 2.0×	57 1.0×	22	666
Devang Panchal Canada	5	303 1.2×	235 1.4×	190 1.1×	108 0.9×	24 0.4×	7	511
E. Wunder France	11	306 1.2×	147 0.8×	202 1.2×	97 0.8×	61 1.1×	28	696
V.C.G. Tjan-Heijnen Netherlands	9	212 0.8×	164 0.9×	240 1.4×	159 1.4×	60 1.1×	18	433
Zsuzsa Rákosy Hungary	15	259 1.0×	277 1.6×	137 0.8×	44 0.4×	51 0.9×	23	511

Countries citing papers authored by Brian Datnow

Since Specialization

Citations

This map shows the geographic impact of Brian Datnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Datnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Datnow more than expected).

Fields of papers citing papers by Brian Datnow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Datnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Datnow. The network helps show where Brian Datnow may publish in the future.

Co-authorship network of co-authors of Brian Datnow

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Datnow. A scholar is included among the top collaborators of Brian Datnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Datnow. Brian Datnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nakashima, Jonathan, Jantzen Sperry, Aliakbar Shahsafaei, et al.. (2021). Abstract 3013: Orthotopic patient-derived xenografts (O-PDX) are effective precision oncology models that can predict therapeutic response, recurrence, and acquired drug resistance. Cancer Research. 81(13_Supplement). 3013–3013. 1 indexed citations

Symmans, W. Fraser, Christina Yau, Yunn‐Yi Chen, et al.. (2018). Residual cancer burden (RCB) as prognostic in the I-SPY 2 TRIAL.. Journal of Clinical Oncology. 36(15_suppl). 520–520. 2 indexed citations

Lwin, Thinzar M., Kentaro Miyake, Takashi Murakami, et al.. (2018). Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 9(99). 37333–37342. 18 indexed citations

Liu, MC, Christina Yau, Yung‐Yi Chen, et al.. (2016). Abstract P3-07-49: Residual cancer burden (RCB) with veliparib/carboplatin in the I-SPY2 trial. Cancer Research. 76(4_Supplement). P3–7. 1 indexed citations

Engelberg, Jesse A., Hanna Retallack, Ronald Balassanian, et al.. (2015). “Score the Core” Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Human Pathology. 46(11). 1694–1704. 11 indexed citations

Schwaederlé, Maria, Barbara A. Parker, Richard B. Schwab, et al.. (2014). Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience. The Oncologist. 19(6). 631–636. 133 indexed citations

Heavey, Susan, Eric Roeland, Ann Tipps, Brian Datnow, & Jason K. Sicklick. (2014). Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies.. PubMed. 5(4). E58–64. 1 indexed citations

Garmy‐Susini, Barbara, Christie J. Avraamides, Jay S. Desgrosellier, et al.. (2013). PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes. Proceedings of the National Academy of Sciences. 110(22). 9042–9047. 78 indexed citations

Bishop, John W., Jesse A. Engelberg, Sophia K. Apple, et al.. (2012). Raising the bar: Breast cancer biomarkers IHC4 harmonization from University of California-Athena pathology collaboration.. Journal of Clinical Oncology. 30(34_suppl). 80–80. 2 indexed citations

10.

Shabaik, Ahmed, Michael E. Peterson, Farnaz Hasteh, et al.. (2010). Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma. Diagnostic Cytopathology. 39(5). 328–332. 62 indexed citations

11.

Ganesan, Karthik, Claude B. Sirlin, Michael Bouvet, et al.. (2010). Amphicrine carcinoma of the liver. Annals of Diagnostic Pathology. 15(5). 355–357. 10 indexed citations

12.

Denicourt, Catherine, Cheryl Saenz, Brian Datnow, Xian-Shu Cui, & Steven F. Dowdy. (2007). Denicourt, C., Saenz, C. C., Datnow, B., Cui, X. S. & Dowdy, S. F. Relocalized p27KiP1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res. 67, 9238-9243. 19 indexed citations

13.

Denicourt, Catherine, et al.. (2007). Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma. Cancer Research. 67(19). 9238–9243. 88 indexed citations

14.

Datnow, Brian, et al.. (1983). Clinical and histologic features of orf.. PubMed. 32(2). 142–4, 146. 6 indexed citations

15.

Datnow, Brian, et al.. (1974). Acquired (digital) fibrokeratomas. Complication of ingrown toenail. Acta Dermato Venereologica. 54(1). 73–75. 7 indexed citations

16.

Datnow, Brian, et al.. (1974). Acute Myocardial Infarction Due to Chronic Myelogenous Leukemia. CHEST Journal. 65(4). 452–455. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact